» Articles » PMID: 31913699

Mechanisms Involved in AMPK-mediated Deposition of Tight Junction Components to the Plasma Membrane

Overview
Specialties Cell Biology
Physiology
Date 2020 Jan 9
PMID 31913699
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

AMP-activated protein kinase (AMPK) activation promotes early stages of epithelial junction assembly. AMPK activation in MDCK renal epithelial cells facilitates localization of the junction-associated proteins aPKCζ and Par3 to the plasma membrane and promotes conversion of Cdc42, a key regulator of epithelial polarization and junction assembly, to its active GTP bound state. Furthermore, Par3 is an important regulator of AMPK-mediated aPKCζ localization. Both aPKCζ and Par3 serve as intermediates in AMPK-mediated junction assembly, with inhibition of aPKCζ activity or Par3 knockdown disrupting AMPK's ability to facilitate zonula occludens (ZO-1) localization. AMPK phosphorylates the adherens junction protein afadin and regulates its interaction with the tight-junction protein zonula occludens-1. Afadin is phosphorylated at two critical sites, S228 (residing within an aPKCζ consensus site) and S1102 (residing within an AMPK consensus site), that are differentially regulated during junction assembly and that exert different effects on the process. Expression of phospho-defective mutants (S228A and S1102A) perturbed ZO-1 localization to the plasma membrane during AMPK-induced junction assembly. Expression of S228A increased the ZO-1/afadin interaction, while S1102A reduced this interaction during extracellular calcium-induced junction assembly. Inhibition of aPKCζ activity also increased the ZO-1/afadin interaction. Taken together, these data suggest that aPKCζ phosphorylation of afadin terminates the ZO-1/afadin interaction and thus permits the later stages of junction assembly.

Citing Articles

Multi-Omics Profiles of Small Intestine Organoids in Reaction to Breast Milk and Different Infant Formula Preparations.

Wang X, Yang S, Zheng C, Huang C, Yao H, Guo Z Nutrients. 2024; 16(17).

PMID: 39275267 PMC: 11397455. DOI: 10.3390/nu16172951.


Blueberry Stem Extract Prevents Lacrimal Hyposecretion in Non-obese Diabetic Mice Activation of AMPK.

Ogawa K, Ohno Y, Tagashira A, Urata K, Satoh K, Fujimoto N In Vivo. 2023; 37(3):1003-1015.

PMID: 37103112 PMC: 10188039. DOI: 10.21873/invivo.13174.


Junctional integrity and directional mobility of lymphatic endothelial cell monolayers are disrupted by saturated fatty acids.

Tokarz V, Pereira R, Jaldin-Fincati J, Mylvaganam S, Klip A Mol Biol Cell. 2023; 34(4):ar28.

PMID: 36735487 PMC: 10092641. DOI: 10.1091/mbc.E22-08-0367.


Tight junctions: from molecules to gastrointestinal diseases.

Moonwiriyakit A, Pathomthongtaweechai N, Steinhagen P, Chantawichitwong P, Satianrapapong W, Pongkorpsakol P Tissue Barriers. 2022; 11(2):2077620.

PMID: 35621376 PMC: 10161963. DOI: 10.1080/21688370.2022.2077620.


Irisin reduces inflammatory signaling pathways in inflammation-mediated metabolic syndrome.

Slate-Romano J, Yano N, Zhao T Mol Cell Endocrinol. 2022; 552:111676.

PMID: 35569582 PMC: 10084474. DOI: 10.1016/j.mce.2022.111676.


References
1.
Fanning A, Anderson J . Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann N Y Acad Sci. 2009; 1165:113-20. PMC: 3759978. DOI: 10.1111/j.1749-6632.2009.04440.x. View

2.
Lee J, Lee S, Jung J, Kim J, You G, Kim S . Metformin induces Rab4 through AMPK and modulates GLUT4 translocation in skeletal muscle cells. J Cell Physiol. 2010; 226(4):974-81. DOI: 10.1002/jcp.22410. View

3.
Takiar V, Nishio S, Seo-Mayer P, King Jr J, Li H, Zhang L . Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis. Proc Natl Acad Sci U S A. 2011; 108(6):2462-7. PMC: 3038735. DOI: 10.1073/pnas.1011498108. View

4.
Shin K, Fogg V, Margolis B . Tight junctions and cell polarity. Annu Rev Cell Dev Biol. 2006; 22:207-35. DOI: 10.1146/annurev.cellbio.22.010305.104219. View

5.
Shackelford D, Shaw R . The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer. 2009; 9(8):563-75. PMC: 2756045. DOI: 10.1038/nrc2676. View